Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow
Open Access
- 5 November 2012
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 73 (1) , 54-61
Abstract
Background: Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator–activated receptor-γ (PPAR-γ) agonist would mitigate this effect. Methods: An aorta-to-pulmonary-artery shunt was placed in 11 fetal lambs. Lambs received the PPAR-γ agonist rosiglitazone (RG, 3 mg/kg/d, n = 6) or vehicle (n = 5) for 4 wk. Lung tissue from five normal 4-wk-old lambs was used for comparisons. Results: At 4 wk, pulmonary artery pressure (PAP) and vascular resistance (PVR) decreased with inhaled nitric oxide (NO) in RG- and vehicle-treated shunt lambs. PAP and PVR decreased with acetylcholine (Ach) in RG-treated, but not vehicle-treated, shunt lambs. In vehicle-treated shunt lambs, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, rac1, superoxide, and 3-nitrotyrosine (3-NT) levels were increased, and Ser1177 endothelial NO synthase (eNOS) protein was decreased as compared with normal lambs. In RG-treated shunt lambs, NOx, Ser1177 eNOS protein, and eNOS activity were increased, and NADPH activity, rac1, superoxide levels, and 3-NT levels were decreased, as compared with vehicle-treated shunt lambs. PPAR-γ protein expression was lower in vehicle-treated shunt lambs than in normal and RG-treated shunt lambs. Conclusion: The PPAR-γ agonist RG prevents the loss of agonist-induced endothelium-dependent pulmonary vascular relaxation in lambs with increased PBF, in part, due to decreased oxidative stress and/or increased NO production.Keywords
This publication has 28 references indexed in Scilit:
- PPARγ regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-κBAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Rosiglitazone Attenuates Chronic Hypoxia–Induced Pulmonary Hypertension in a Mouse ModelAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling PathwaysJournal of Biological Chemistry, 2007
- The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular DiseasePPAR Research, 2007
- Nitric oxide activation of peroxisome proliferator‐activated receptor gamma through a p38 MAPK signaling pathwayThe FASEB Journal, 2006
- Peroxisome proliferator-activated receptor-γ ligands regulate endothelial membrane superoxide productionAmerican Journal of Physiology-Cell Physiology, 2005
- Effect of Peroxisome Proliferator–Activated Receptor-α and -γ Activators on Vascular Remodeling in Endothelin-Dependent HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Chronic Hypoxia Increases Endothelial Nitric Oxide Synthase Generation of Nitric Oxide by Increasing Heat Shock Protein 90 Association and Serine PhosphorylationCirculation Research, 2002
- Roles of PPARs in health and diseaseNature, 2000
- Biosynthesis of nitric oxide and citrulline from l-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosumBiochemical and Biophysical Research Communications, 1992